State Street Corp Assembly Biosciences, Inc. Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$1.46 - $2.45 $28,779 - $48,294	19,712 Added 15.69%	145,335 $299,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $3.9 $140,672 - $174,720	-44,800 Reduced 26.29%	125,623 $437,000
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $1.68 Million - $2.02 Million	-442,313 Reduced 72.19%	170,423 $661,000
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $91,934 - $140,768	-21,232 Reduced 3.35%	612,736 $2.82 Million
Q4 2020 Feb 16, 2021	SELL	$4.87 - $17.29 $2.67 Million - $9.47 Million	-547,907 Reduced 46.36%	633,968 $3.84 Million
Q3 2020 Nov 10, 2020	BUY	$15.08 - $27.04 $2.3 Million - $4.12 Million	152,492 Added 14.81%	1,181,875 $19.4 Million
Q2 2020 Aug 14, 2020	BUY	$14.57 - $23.96 $6.97 Million - $11.5 Million	478,059 Added 86.71%	1,029,383 $24 Million
Q1 2020 May 11, 2020	BUY	$10.27 - $21.23 $5.66 Million - $11.7 Million	551,324 New	551,324 $8.18 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $765M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.